Last update Dec. 21, 2023
Very Low Risk
Flecainide is a class Ic antiarrhythmic agent used to treat atrial fibrillation and paroxysmal supraventricular tachycardias. It has also been tried to treat neuropathic pain. Oral or intravenous administration.
It is excreted in breast milk in a very small, clinically insignificant amount, much lower than the dose used in newborns and infants. (van der Zande 2023, McQuinn 1990, Wagner 1990)
In infants of mothers treated with flecainide no problems have been observed and its plasma levels were undetectable. (van der Zande 2023, Pizzoglio 2023)
American Academy of Pediatrics: medication generally compatible with breastfeeding. (AAP 2001)
We do not have alternatives for Flecainide Acetate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM